Imatinib in 34 patients with steroid-refractory chronic graft-versus-host-disease : final evaluation of the second prospective trial, according to the NIH Consensus criteria for cGvHD

Olivieri, A.; Cimminiello, M.; Corradini, P.; Iacopino, P.; Patriarca, F.; Mordini, N.; Donelli, A.; Onida, F.; Selleri, C.; Pavone, V.; Nuccorini, R.; Pascale, S.; Coluzzi, S.; Svegliati, S.; Gabrielli, A.; Leoni, P.; Olivieri, I.; Bacigalupo, A.

doi:10.1038/bmt.2012.36

Imatinib in 34 patients with steroid-refractory chronic graft-versus-host-disease : final evaluation of the second prospective trial, according to the NIH Consensus criteria for cGvHD / A. Olivieri, M. Cimminiello, P. Corradini, P. Iacopino, F. Patriarca, N. Mordini, A. Donelli, F. Onida, C. Selleri, V. Pavone, R. Nuccorini, S. Pascale, S. Coluzzi, S. Svegliati, A. Gabrielli, P. Leoni, I. Olivieri, A. Bacigalupo. - In: BONE MARROW TRANSPLANTATION. - ISSN 0268-3369. - 47:suppl. 1(2012), pp. S62-S63. (Intervento presentato al 38. convegno Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) tenutosi a Geneva nel 2012) [10.1038/bmt.2012.36].